Literature DB >> 23984825

Protective effects of farrerol against hydrogen-peroxide-induced apoptosis in human endothelium-derived EA.hy926 cells.

Jian-Kuan Li1, Rui Ge, Li Tang, Qing-Shan Li.   

Abstract

Vascular endothelium plays an important role in the physiological homeostasis of blood vessels. Endothelial injury is considered to be implicated in the pathogenesis of many cardiovascular diseases, including atherosclerosis. Farrerol, a flavonoid considered to be the major bioactive component in a traditional Chinese herb, "Man-shan-hong", which is the dried leaves of Rhododendron dauricum L., displays many bioactive properties, including antibechic, antibacterial, anti-inflammatory, and the inhibition of vascular smooth muscle cell (VSMC) proliferation. In this study, the protective effects of farrerol on hydrogen peroxide (H2O2)-induced apoptosis in human endothelium-derived EA.hy926 cells were investigated. The results showed that farrerol significantly inhibited the loss of cell viability and enhanced superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in H2O2-induced EA.hy926 cells. Meanwhile, farrerol inhibited H2O2-induced elevation in the levels of intracellular malondialdehyde and reactive oxygen species, as well as cell apoptosis. Furthermore, real time RT-PCR and Western blot analysis showed that farrerol significantly decreased the expression of Bax mRNA, Bax, cleaved caspase-3, and phosph-p38 MAPK, while increasing the exporession of Bcl-2 mRNA and Bcl-2 in H2O2-induced EA.hy926 cells. These results are the first demonstration that farrerol has protective effects against H2O2-induced apoptosis in EA.hy926 cells, and suggests that farrerol is a potential candidate for the intervention of endothelial-injury-associated cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23984825     DOI: 10.1139/cjpp-2013-0008

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  8 in total

Review 1.  Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms.

Authors:  Qing Liu; Jianping Li; Adam Hartstone-Rose; Jing Wang; Jiqiang Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-18       Impact factor: 2.629

2.  Heteromeles Arbutifolia, a Traditional Treatment for Alzheimer's Disease, Phytochemistry and Safety.

Authors:  Xiaogang Wang; Raphael Dubois; Caitlyn Young; Eric J Lien; James D Adams
Journal:  Medicines (Basel)       Date:  2016-07-07

Review 3.  Antioxidants and Atherosclerosis: Mechanistic Aspects.

Authors:  Khojasteh Malekmohammad; Robert D E Sewell; Mahmoud Rafieian-Kopaei
Journal:  Biomolecules       Date:  2019-07-25

4.  The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review.

Authors:  Xiaojiang Qin; Xinrong Xu; Xiaomin Hou; Ruifeng Liang; Liangjing Chen; Yuxuan Hao; Anqi Gao; Xufeng Du; Liangyuan Zhao; Yiwei Shi; Qingshan Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

5.  Farrerol Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting Macrophages and NLRP3.

Authors:  Lin Zhou; Shuhui Yang; Xiaoming Zou
Journal:  Front Pharmacol       Date:  2022-04-13       Impact factor: 5.988

6.  Oridonin Attenuates Burkholderia cenocepacia Virulence by Suppressing Quorum-Sensing Signaling.

Authors:  Xia Li; Kai Wang; Gerun Wang; Binbin Cui; Shihao Song; Xiuyun Sun; Yinyue Deng
Journal:  Microbiol Spectr       Date:  2022-07-20

7.  Relaxation of rat aorta by farrerol correlates with potency to reduce intracellular calcium of VSMCs.

Authors:  Xiaojiang Qin; Xiaomin Hou; Mingsheng Zhang; Taigang Liang; Jianmin Zhi; Lingge Han; Qingshan Li
Journal:  Int J Mol Sci       Date:  2014-04-17       Impact factor: 5.923

8.  Farrerol Directly Targets GSK-3β to Activate Nrf2-ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress-Induced Injuries.

Authors:  Chaoqun Yan; Xiaoyan Zhang; Junqiu Miao; Hongxia Yuan; Enli Liu; Taigang Liang; Qingshan Li
Journal:  Oxid Med Cell Longev       Date:  2020-01-28       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.